ClinicalTrials.Veeva

Menu

Indices of Severity and Prognosis for Sickle Cell Disease

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Blood Disease
Anemia, Sickle Cell

Study type

Observational

Funder types

NIH

Identifiers

NCT00005467
4912
R01HL042498 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

To develop a clinical severity index that could prospectively identify sickle cell disease patients who were at high risk for a turbulent clinical course and a poor prognosis.

Full description

DESIGN NARRATIVE:

Using the database, univariate analysis showed that factors associated with the occurrence of cerebrovascular accident (51 patients) included hematocrit, rate of change of pocked red cell count, and polymer fraction at 40 percent oxygen saturation (PF40). Only low hematocrit was predictive of death in the pediatric cohort. There were 45 disease-related deaths.

The study completion date listed in this record was obtained from the "End Date" entered in the Protocol Registration and Results System (PRS) record.

Sex

Male

Ages

Under 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

No eligibility criteria

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems